(Q44424701)

2 December 2017

Fatal labetalol-induced hepatic injury (English)

1 reference

2 December 2017

D D Douglas

1

1 reference

2 December 2017

R D Yang

series ordinal

2

1 reference

2 December 2017

P Jensen

series ordinal

3

1 reference

2 December 2017

D L Thiele

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

American Journal of Medicine

2 December 2017

1 reference

2 December 2017

87

1 reference

2 December 2017

2

1 reference

2 December 2017

235-236

1 reference

Metoprolol-induced hepatitis: rechallenge and drug oxidation phenotyping

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980706-5

Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980706-5

Appraisal of the mortality in acute fulminant viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980706-5

SLE syndrome, probably induced by labetalol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980706-5

Anti-mitochondrial antibodies associated with labetalol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980706-5

Antimitochondrial antibodies associated with labetalol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980706-5

Genetically determined polymorphisms in drug oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980706-5

10.1016/S0002-9343(89)80706-5

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference